Company news

Wave Life Sciences Ltd. news in 2023

Wave Life Sciences Ltd.'s news releases, calls and decks from 2023, newest first.

View company

Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular Dystrophy

December 14, 2023

Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares

December 6, 2023

Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA Editing Candidate, WVE-006, for Alpha-1 Antitrypsin Deficiency

December 5, 2023

Wave Life Sciences to Present at 6ᵗʰ Annual Evercore ISI HealthCONx Conference

November 21, 2023

Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

November 8, 2023

Wave Life Sciences Third Quarter 2023 Financial Results Scheduled for November 9, 2023

November 2, 2023

Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annual R&D Day

September 27, 2023

Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference

September 24, 2023

Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference

September 5, 2023

Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-006, the First-ever RNA Editing Clinical Candidate, and Plans for Upcoming Virtual “R&D Day”

September 4, 2023

Wave Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update

August 2, 2023

Wave Life Sciences Second Quarter 2023 Financial Results Scheduled for August 3, 2023

July 26, 2023

Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes

June 25, 2023

Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

May 22, 2023

Wave Life Sciences to Highlight Leading RNA Editing Capability and Multimodal Discovery and Development Platform at ASGCT 26th Annual Meeting

May 15, 2023

Wave Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update

May 2, 2023

Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023

April 25, 2023

Wave Life Sciences Announces Nucleic Acids Research Publication Highlighting Potential Best-in-Class siRNAs Designed with Wave Platform Chemistry

April 19, 2023

Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days

March 28, 2023

Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

March 21, 2023

Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023

March 1, 2023

Wave Life Sciences to Present at the 2023 Virtual SVB Securities Global Biopharma Conference

February 8, 2023

Calls in 2023

Decks in 2023